Donald Ludovici

1.5k total citations
8 papers, 781 citations indexed

About

Donald Ludovici is a scholar working on Infectious Diseases, Virology and Organic Chemistry. According to data from OpenAlex, Donald Ludovici has authored 8 papers receiving a total of 781 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 6 papers in Virology and 4 papers in Organic Chemistry. Recurrent topics in Donald Ludovici's work include HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (6 papers) and Click Chemistry and Applications (2 papers). Donald Ludovici is often cited by papers focused on HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (6 papers) and Click Chemistry and Applications (2 papers). Donald Ludovici collaborates with scholars based in United States and Belgium. Donald Ludovici's co-authors include Michael J. Kukla, Rudi Pauwels, Koen Andries, Hilde Azijn, Jan Heeres, Marie‐Pierre de Béthune, Bart De Corte, Paul Janssen, Johan Vingerhoets and Chih Y. Ho and has published in prestigious journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Donald Ludovici

8 papers receiving 758 citations

Peers

Countries citing papers authored by Donald Ludovici

Since Specialization

Citations

This map shows the geographic impact of Donald Ludovici's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald Ludovici with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald Ludovici more than expected).

Fields of papers citing papers by Donald Ludovici

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald Ludovici. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald Ludovici. The network helps show where Donald Ludovici may publish in the future.

Co-authorship network of co-authors of Donald Ludovici

This figure shows the co-authorship network connecting the top 25 collaborators of Donald Ludovici. A scholar is included among the top collaborators of Donald Ludovici based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald Ludovici. Donald Ludovici is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	Arylglycine derivatives as potent transient receptor potential melastatin 8 (TRPM8) antagonists 2013 ·Bioorganic & Medicinal Chemistry Letters ·Bin Zhu, Mingde Xia, (unknown), Donald Ludovici, Manomi A. Tennakoon, Mark A. Youngman, Jay M. Matthews, Scott L. Dax, Raymond W. Colburn, Na Qin, Tasha L. Hutchinson, Mary Lou Lubin, Michael R. Brandt, Dennis J. Stone, Christopher M. Flores, Mark J. Macielag	24
2	TMC125, a Novel Next-Generation Nonnucleoside Reverse Transcriptase Inhibitor Active against Nonnucleoside Reverse Transcriptase Inhibitor-Resistant Human Immunodeficiency Virus Type 1 2004 ·Antimicrobial Agents and Chemotherapy ·Koen Andries, Hilde Azijn, (unknown), Donald Ludovici, Michael J. Kukla, Jan Heeres, Paul Janssen, Bart De Corte, Johan Vingerhoets, Rudi Pauwels, Marie‐Pierre de Béthune	265
3	On the detection of multiple-binding modes of ligands to proteins, from biological, structural, and modeling data 2003 ·Journal of Computer-Aided Molecular Design ·Paul Lewis, Marc R. de Jonge, Frits Daeyaert, Luc Koymans, Maarten Vinkers, Jan Heeres, Paul A. J. Janssen, Eddy Arnold, Kalyan Das, (unknown), Stephen H. Hughes, Paul L. Boyer, Marie‐Pierre de Béthune, Rudi Pauwels, Koen Andries, (unknown), Donald Ludovici, Bart De Corte, Robert W. Kavash, Chih Y. Ho	41
4	Evolution of Anti-HIV Drug CandidatesPart 2: Diaryltriazine (DATA) Analogues 2001 ·Bioorganic & Medicinal Chemistry Letters ·Donald Ludovici, Robert W. Kavash, Michael J. Kukla, Chih Y. Ho, Hong Ye, (unknown), Koen Andries, Marie‐Pierre de Béthune, Hilde Azijn, Rudi Pauwels, (unknown), Jan Heeres, Lucien M. H. Koymans, Marc R. de Jonge, Koen Van Aken, (unknown), Paul Lewi, Kalyan Das, Eddy Arnold, Paul A. J. Janssen	98
5	Evolution of anti-HIV drug candidates. Part 1: From α-Anilinophenylacetamide (α-APA) to imidoyl thiourea (ITU) 2001 ·Bioorganic & Medicinal Chemistry Letters ·Donald Ludovici, Michael J. Kukla, (unknown), Suma Krishnan, Koen Andries, (unknown), Hilde Azijn, Rudi Pauwels, Erik De Clercq, Eddy Arnold, (unknown)	62
6	Evolution of anti-HIV drug candidates. Part 3: diarylpyrimidine (DAPY) analogues 2001 ·Bioorganic & Medicinal Chemistry Letters ·Donald Ludovici, (unknown), Michael J. Kukla, Hong Ye, Chih Y. Ho, (unknown), Robert W. Kavash, Koen Andries, (unknown), Hilde Azijn, Rudi Pauwels, Paul Lewi, Jan Heeres, Lucien M. H. Koymans, Marc R. de Jonge, Koen Van Aken, (unknown), Kalyan Das, Eddy Arnold, Paul A. J. Janssen	154
7	Synthesis and Anti-HIV-1 Activity of 4,5,6,7-Tetrahydro-5-methylimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one (TlBO) Derivatives. 4 1995 ·Journal of Medicinal Chemistry ·Winston G. Ho, Michael J. Kukla, Henry J. Breslin, Donald Ludovici, (unknown), Craig J. Diamond, Milton Edson Miranda, James D. Rodgers, Chih Y. Ho	52
8	Synthesis and Anti-HIV-1 Activity of 4,5,6,7-Tetrahydro-5-methylimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one (TIBO) Derivatives. 3 1995 ·Journal of Medicinal Chemistry ·Henry J. Breslin, Michael J. Kukla, Donald Ludovici, Richard J. Mohrbacher, Winston G. Ho, Milton Edson Miranda, James D. Rodgers, T. Kevin Hitchens, Gregory C. Leo	85

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact